92 related articles for article (PubMed ID: 3261582)
1. Human monoclonal anti-idiotypic antibodies as an epitope vaccine against pancreatic carcinoma.
Bosslet K; Büchler M; Klapdor R; Muhrer C; Sedlacek HH; Schulz G
Behring Inst Mitt; 1988 Apr; (82):193-6. PubMed ID: 3261582
[TBL] [Abstract][Full Text] [Related]
2. Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies.
Steinitz M; Tamir S; Frödin JE; Lefvert AK; Mellstedt H
J Immunol; 1988 Nov; 141(10):3516-22. PubMed ID: 2846688
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
4. Idiotypic determinants on human T cells and modulation of human T cell responses by anti-idiotypic antibodies.
Geha RS
J Immunol; 1984 Oct; 133(4):1846-51. PubMed ID: 6206140
[TBL] [Abstract][Full Text] [Related]
5. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
Tamura GS; McGrath MS; Weissman IL
J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
[TBL] [Abstract][Full Text] [Related]
6. Anti-idiotypic antibodies to monoclonal antibody CO17-1A.
Herlyn D; Sears H; Iliopoulos D; Lubeck M; Douillard JY; Sindelar W; Tempero M; Mellstedt H; Maher M; Koprowski H
Hybridoma; 1986 Jul; 5 Suppl 1():S51-8. PubMed ID: 3488951
[TBL] [Abstract][Full Text] [Related]
7. [Application of monoclonal antibodies to cancer therapy: idiotype mapping of monoclonal antibodies to tumor-associated antigens].
Imai K; Tsujisaki M; Yachi A
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1051-9. PubMed ID: 3291766
[TBL] [Abstract][Full Text] [Related]
8. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA
J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against urinary light chain idiotypes as agents for detection and destruction of human neoplastic B lymphocytes.
Tutt AL; Stevenson FK; Smith JL; Stevenson GT
J Immunol; 1983 Dec; 131(6):3058-63. PubMed ID: 6417240
[TBL] [Abstract][Full Text] [Related]
10. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactive idiotypes on high affinity IgG class human monoclonal thyroglobulin autoantibodies.
Delves PJ; McLachlan SM; Drewe E; Fukuma N; Petersen VB; Smith BR
J Autoimmun; 1993 Feb; 6(1):77-91. PubMed ID: 8457287
[TBL] [Abstract][Full Text] [Related]
12. Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes.
Bhattacharya-Chatterjee M; Pride MW; Seon BK; Kohler H
J Immunol; 1987 Aug; 139(4):1354-60. PubMed ID: 3497200
[TBL] [Abstract][Full Text] [Related]
13. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
14. Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.
Thielemans K; Maloney DG; Meeker T; Fujimoto J; Doss C; Warnke RA; Bindl J; Gralow J; Miller RA; Levy R
J Immunol; 1984 Jul; 133(1):495-501. PubMed ID: 6609992
[TBL] [Abstract][Full Text] [Related]
15. Two Ia.17-specific monoclonal antibodies detect the same epitope but do not share idiotype.
Sher MR; Bender TP; Niederhuber JE
J Immunol; 1984 Jul; 133(1):338-44. PubMed ID: 6202786
[TBL] [Abstract][Full Text] [Related]
16. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
Qian GX; Fu SM; Solanki DL; Rai KR
J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459
[TBL] [Abstract][Full Text] [Related]
17. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
[TBL] [Abstract][Full Text] [Related]
18. [Reactivity of a natural human monoclonal polyreactive antibody with exogenous and endogenous antigens and its possible role in an idiotypic-anti-idiotypic network].
Roggenbuck D; Kaufmann J; Franz J; Marx U; Schoenherr G; Jahn S; Porstmann T
Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):485-9. PubMed ID: 7856249
[No Abstract] [Full Text] [Related]
19. Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes.
Fagerberg J; Hjelm AL; Ragnhammar P; Frödin JE; Wigzell H; Mellstedt H
Cancer Res; 1995 May; 55(9):1824-7. PubMed ID: 7728746
[TBL] [Abstract][Full Text] [Related]
20. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
George AJ; Tutt AL; Stevenson FK
J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]